Depression is one of the most disabling conditions in the world, and many patients
do not achieve full remission with standard treatments. There has been increasing
interest in dietary supplements as potential adjuncts to standard treatments for
depression. This narrative review examines the evidence regarding vitamin D,
creatine, folic acid and omega-3 fatty acids in depressive disorders, with a focus on
their potential use alongside standard treatment. A search of PubMed and Google
Scholar was performed to identify meta-analyses, systematic reviews and
randomised controlled trials evaluating these supplements in the treatment of
depression. All four supplements examined have been associated with reductions in
depressive symptoms. Vitamin D and omega-3 fatty acids have shown benefits in
people with depressive disorders, while folic acid may be beneficial as an adjunct to
antidepressants in people with low folate levels. Creatine has also shown some
benefits in people taking antidepressants or undergoing cognitive behavioural
therapy, although results are not yet conclusive. These findings suggest that dietary
supplements could play a role in the treatment of depression, albeit as an adjunct to
antidepressant medication. Further studies are required to determine optimal
dosing and treatment duration, as well as the patient populations most likely to
benefit.
Keywords: Supplementation, vitamin D, creatine, folic acid, omega-3 fatty acids,
depression, depressive symptoms
